Mark FOLEY

Mark J. Foley has served as President and Chief Executive Officer of ZELTIQ Aesthetics (ZLTQ) since April of 2012. Mr. Foley initially joined ZELTIQ in 2009 as Executive Chairman and as a member of the Board of Directors. Additionally, he serves as a Managing Director at RWIVentures and as Executive Chairman at Onpharma. Prior to this, Mr. Foley held a variety of operating roles in large, public companies and venture-backed startups including US Surgical Corporation, Guidant Corporation, Devices for VascularIntervention (acquired by Eli Lilly), Perclose (acquired by Abbott) and Ventrica (acquired by Medtronic) where he was the founder and CEO. Mr. Foley has over 25 years of medical device operating, investment and CEO experience. Additionally, he has partnered with a number of entrepreneurs to assist with the formation and capitalization of new companies. Mr. Foley serves or has served as Senior Advisor, Executive Chairman, Interim CEO and Board Member to a number of medical device companies. Mr. Foley received his B.A. from the University of Notre Dame.